« Government Targeting Pharmaceutical Executives with Renewed Enthusiasm | Main | FDA REMS: Blue Print for Prescriber Continuing Education Program for Extended Release-Long Acting Opioids »

November 07, 2011


TrackBack URL for this entry:

Listed below are links to weblogs that reference NY Times: Medical Experts on Guidelines Panels - Not Welcome?:


Feed You can follow this conversation by subscribing to the comment feed for this post.

"Freedom from experts is not the answer. A principled expert with experience, in the end is good for patient care and should be a welcome addition to guidelines panels."

Agreed. At the end of the day, it is impossible to get completely free from any potential conflicts of interest. The only way to do that is to select individuals who are so ignorant of medical trials altogether that their opinion on such would be next to worthless.

The comments to this entry are closed.


Best Healthcare Blogs 2012
Enter your Email:
Preview | Powered by FeedBlitz

March 2015

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31